Updates to Dementia – Alzheimer’s, Insomnia, and Ulcerative Colitis All TreatGx users now have access to the updated treatment algorithms for Dementia – Alzheimer’s [1-7], Insomnia [8], and Ulcerative Colitis [9-11]. As always, all updates include the TreatGx standard of providing personalized dosing based on pharmacogenetics,…
NUDT15 update With the recent Crohn’s Disease update, we have also updated the way our software processes NUDT15 genetic data. Previously, the software assessed reported genotypes for NUDT15 rs116855232. With this update, we now assess drug-gene interactions with NUDT15 based on…
All TreatGx users now have access to the updated Crohn’s disease treatment algorithm. Crohn’s Disease This comprehensive update incorporates information from AGA 2021[1] and ACG 2018[2] to help clinicians personalize treatment for their patients. A key update to this algorithm is…
TreatGx users now have access to the updated treatment algorithm for Chronic Obstructive Pulmonary Disease (COPD) – Acute Exacerbation. As always, this update includes the TreatGx standard of providing personalized dosing based on kidney function, liver function, and drug interactions. This…
TreatGx users now have access to the updated treatment algorithm for Rheumatoid Arthritis. As always, this update includes the TreatGx standard of providing personalized dosing based on kidney function, liver function, and drug interactions. This is based on the 2021 American…
All TreatGx users now have access to the updated treatment algorithms for Post-Myocardial Infarction and Hyperlipidemia. As always, these updates include the TreatGx standard of providing personalized dosing based on pharmacogenetics, kidney function, liver function, and drug interactions. In this update,…
All TreatGx users now have access to the updated treatment algorithm for Atrial Fibrillation – Anticoagulation: Warfarin. Warfarin dosing update The atrial fibrillation anticoagulation algorithm now provides updated dosing information for warfarin, including recommendations from the Clinical Pharmacogenetics Implementation Consortium (CPIC)…
All TreatGx users now have access to the updated treatment algorithms for Depression, Bipolar 1 Disorder, and Heart Failure – Chronic. As always, all updates include the TreatGx standard of providing personalized dosing based on pharmacogenetics, kidney function, liver function, contraindications, allergies/intolerances, and drug-drug interactions. Depression…
To improve the usability of TreatGx, our Urinary Tract Infection treatment algorithm has been split into individual conditions: Urinary Tract Infection – Cystitis (Empiric therapy) and Urinary Tract Infection – Pyelonephritis (Empiric therapy). The greatest advantage to users is that there…
This update accounts for revisions made to existing clinical guidelines and will help health care providers select the safest and most effective medications with their patients. This update follows the recommendations from the 2019 American College of Rheumatology Foundation Guideline for…